Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis

Systemic reactive AA amyloidosis is a life-threatening complication of chronic inflammatory diseases. Anti-interleukin-6 receptor, tocilizumab (TCZ), has been shown to improve clinical symptoms of patients with AA amyloidosis, accompanied with regression of the amyloid deposition. We report a case o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Matsui, Masaru, Okayama, Satoshi, Tsushima, Hideo, Samejima, Kenichi, Kanki, Tomoko, Hasegawa, Ayako, Morimoto, Katsuhiko, Akai, Yasuhiro, Takano, Masato, Uemura, Shiro, Ohbayashi, Chiho, Saito, Yoshihiko
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145365/
https://ncbi.nlm.nih.gov/pubmed/25197587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/823093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados